Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AVECHO BIOTECHNOLOGY LIMITED Call Transcript 2015

Jun 30, 2015

64468_rns_2015-06-30_68f3899c-0883-4c37-803c-cb9338c12b85.pdf

Call Transcript

Open in viewer

Opens in your device viewer

ASX Limited Market Announcements Office

==> picture [233 x 40] intentionally omitted <==

Quarterly Shareholder Update

1 July 2015, Melbourne, Australia

Phosphagenics Limited (ASX: POH; OTCQX: PPGNY) invites shareholders to participate in the first of our quarterly updates.

The details to join the teleconference are below:

Date: 10[th] July 2015 Time: 9:00 am AEST

Dial in Numbers:

Australia* 1800 064291
UK # 0800 0324417
USA* 1866 8301117
New Zealand* 0800 441278
Singapore* 800 6161 919
Japan* 0034 800 400541
Hong Kong* 800 968665
Australia Metered 03 8605 4949
InternationalMetered +61 3 86054949

Participant Call-In Reference Guide

PLEASE NOTE: to contribute in a Telstra Conferencing Question Queuing Presentation, you will need a touchtone phone.

  • Approximately 10 minutes before the scheduled start time, please dial your above Call‐In number.

  • A Conference Administrator will greet you and obtain your full name and any other required details. You will be asked to test the * then 1 keys on your telephone to ensure that you are able to register questions, if required. You will then be placed into hold music until the conference is due to commence.

  • At the start of the conference you will be taken off hold music and placed in a Listen Only (mute) Mode; there is no need for you to mute your own phone line.

  • If at any time during the conference you wish to ask a question or make a comment, press ( then 1) to register your question.* The Conference Administrator will un‐mute your line and introduce you, in turn, to ask your question. If you decide to cancel your question at any time press ( then 2).* All parties in the conference will hear your questions, comments and answers. When you have finished asking your question(s) and have received your answer(s) you will be placed back into conference on Listen Only Mode.

  • If you are disconnected for any reason during the conference, please redial your above Call‐in number.

  • The Presenter will inform all participants once the conference is about to conclude.

Phosphagenics Limited

ACN 056 482 403 ABN 32 056 482 403

11 Duerdin Street, Clayton VIC 3168 PO Box 1415, Clayton South MDC VIC 3169 Australia Tel: +61 (0)3 9565 1119 Fax: +61 (0)3 9565 1151 www.phosphagenics.com Email: [email protected]

Enquiries

Dr Ross Murdoch CEO Phosphagenics Limited +61 3 9565 1119

David Segal Investor Relations Manager Phosphagenics Limited +61 3 9565 1103

About Phosphagenics

Phosphagenics Limited is a drug delivery company that is commercialising various products within the pharmaceutical, cosmetics and animal health sectors, using its proprietary drug delivery system called TPM[® ] (Targeted Penetration Matrix). TPM[®] is a patient friendly and cost effective system, based on Vitamin E, that enhances the topical or transdermal delivery of active molecules. The lead products advancing through clinical trials are oxymorphone and oxycodone patches for the relief of chronic pain.

Phosphagenics' shares are listed on the Australian Securities Exchange (POH) and its ADR – Level 1 program in the US is with The Bank of New York Mellon (PPGNY).

www.phosphagenics.com

Page 2 of 2